Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug2450 | Mupirocin Wiki | 1.00 |
| drug4585 | modified IPAC-UHN PPE Wiki | 1.00 |
| drug2401 | Minocycline Wiki | 1.00 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
This study proposes to compare the effectiveness of two different levels of PPE in protecting front-line health care workers from self-contamination with droplets and aerosolized particles during a simulated endotracheal intubation, an aerosol-generating medical procedure.
Description: Incidence of contamination of any part of the base clothing or exposed skin of the upper body (head or neck, forearms, arms, wrists, hands or torso)
Measure: Incidence of contamination of any part of the base clothing or exposed skin of the upper body Time: 0-1 hour After doffing is completeDescription: For the purpose of this outcome, the body will be divided in the following 10 areas: a) face, b) hair or posterior aspect of the head, c) right side of the neck, d) left side of the neck, e) right arm or forearm, f) left arm or forearm, g) left wrist or hand, h) right wrist or hand, i) torso, j) right or left lower extremity.
Measure: 1) Number of body areas contaminated Time: 0-1 hour After doffing is completeDescription: Number of discrete areas of contamination of <1 cm2 and >1 cm2
Measure: 2) Number of discrete areas of contamination of <1 cm2 and >1 cm2 Time: 0-1 hour After doffing is completeDescription: Rated by each subject on an 11-point numeric rating scale from 0 (no visibility due to fogging or physical interference of the PPE, leading to inability to perform the required procedures) to 10 (perfect visibility, no fogging or physical interference with required tasks)
Measure: 3) Visibility during the simulated procedure Time: 0-1 hour After doffing is completeDescription: Assessed using an 11-point numeric rating scale from 0 = extremely difficult PPE made it impossible to intubate, to 10 = Absolutely no obstruction or difficulty added by the PPE
Measure: 4) Ease of intubation procedures when wearing PPE Time: 0-1 hour After doffing is completeDescription: Assessed using an 11-point numeric rating scale from 0=felt suffocated, needed to remove the PPE before completing the task to 10 = no difficulty breathing
Measure: 5) Ease of breathing while wearing PPE Time: 0-1 hour After doffing is completeDescription: Reported on an 11-point numeric rating scale from 0 = extremely hot, needed to remove the PPE before completing the tasks to 10= no discomfort due to temperature
Measure: 6) Thermal comfort while wearing the PPE Time: 0-1 hour After doffing is completeDescription: Doffing violations will be documented and will be defined as performing a maneuver out of sequence, touching an item of clothing out of sequence, tearing an item of protective clothing, or touching any body part other than an item of protective clothing before performing hand hygiene.
Measure: 7) Incidence of breaching of doffing procedures Time: 0-1 hour After doffing is completeAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports